These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22401133)

  • 1. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.
    Viktil KK; Engeland A; Furu K
    Scand J Rheumatol; 2012 May; 41(3):196-201. PubMed ID: 22401133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of antirheumatic drugs in mothers and fathers before and during pregnancy-a population-based cohort study.
    Viktil KK; Engeland A; Furu K
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):737-42. PubMed ID: 19504626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes.
    Chakravarty EF; Sanchez-Yamamoto D; Bush TM
    J Rheumatol; 2003 Feb; 30(2):241-6. PubMed ID: 12563675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study.
    Weber-Schoendorfer C; Chambers C; Wacker E; Beghin D; Bernard N; ; Shechtman S; Johnson D; Cuppers-Maarschalkerweerd B; Pistelli A; Clementi M; Winterfeld U; Eleftheriou G; Pupco A; Kao K; Malm H; Elefant E; Koren G; Vial T; Ornoy A; Meister R; Schaefer C
    Arthritis Rheumatol; 2014 May; 66(5):1101-10. PubMed ID: 24470106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.
    Weber-Schoendorfer C; Hoeltzenbein M; Wacker E; Meister R; Schaefer C
    Rheumatology (Oxford); 2014 Apr; 53(4):757-63. PubMed ID: 24369411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.
    Strangfeld A; Hierse F; Kekow J; von Hinueber U; Tony HP; Dockhorn R; Listing J; Zink A
    Ann Rheum Dis; 2009 Dec; 68(12):1856-62. PubMed ID: 19126559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive study.
    Vroom F; van Roon EN; van den Berg PB; Brouwers JR; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):52-61. PubMed ID: 17948319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease.
    Østensen M; von Esebeck M; Villiger PM
    J Rheumatol; 2007 Jun; 34(6):1266-9. PubMed ID: 17516615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No excess risks in offspring with paternal preconception exposure to disease-modifying antirheumatic drugs.
    Wallenius M; Lie E; Daltveit AK; Salvesen KÅ; Skomsvoll JF; Kalstad S; Lexberg ÅS; Mikkelsen K; Kvien TK; Østensen M
    Arthritis Rheumatol; 2015 Jan; 67(1):296-301. PubMed ID: 25418443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.
    Hetland ML; Christensen IJ; Tarp U; Dreyer L; Hansen A; Hansen IT; Kollerup G; Linde L; Lindegaard HM; Poulsen UE; Schlemmer A; Jensen DV; Jensen S; Hostenkamp G; Østergaard M;
    Arthritis Rheum; 2010 Jan; 62(1):22-32. PubMed ID: 20039405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis.
    Schneeweiss S; Setoguchi S; Weinblatt ME; Katz JN; Avorn J; Sax PE; Levin R; Solomon DH
    Arthritis Rheum; 2007 Jun; 56(6):1754-64. PubMed ID: 17530704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
    Narváez J; Díaz-Torné C; Ruiz JM; Hernández MV; Torrente-Segarra V; Ros S; Rodriguez de la Serna A; Díaz-López C; Sanmartí R; Nolla JM
    Semin Arthritis Rheum; 2011 Dec; 41(3):401-5. PubMed ID: 21862107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid monotherapy in pregnancy and major congenital malformations.
    Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
    N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate.
    Wolfe F; Michaud K; Stephenson B; Doyle J
    J Rheumatol; 2003 Aug; 30(8):1725-32. PubMed ID: 12913927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription drug use among pregnant women in opioid Maintenance Treatment.
    Lund IO; Skurtveit S; Engeland A; Furu K; Ravndal E; Handal M
    Addiction; 2013 Feb; 108(2):367-76. PubMed ID: 22882166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database.
    Carter JD; Ladhani A; Ricca LR; Valeriano J; Vasey FB
    J Rheumatol; 2009 Mar; 36(3):635-41. PubMed ID: 19132789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcome in women exposed to leflunomide before or during pregnancy.
    Cassina M; Johnson DL; Robinson LK; Braddock SR; Xu R; Jimenez JL; Mirrasoul N; Salas E; Luo YJ; Jones KL; Chambers CD;
    Arthritis Rheum; 2012 Jul; 64(7):2085-94. PubMed ID: 22307734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
    Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006.
    Engeland A; Bramness JG; Daltveit AK; Rønning M; Skurtveit S; Furu K
    Br J Clin Pharmacol; 2008 May; 65(5):653-60. PubMed ID: 18294334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.